Takano M et al. |
Synthesis and biological activity of 1α,2α,25-trihydroxyvitamin D3: active metabolite of 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 by human CYP3A4. |
2014 |
Chem. Pharm. Bull. |
pmid:24492588
|
Miller RE et al. |
Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection. |
2007 |
J. Immunol. |
pmid:17579046
|
Esteban LM et al. |
Promoter-, cell-, and ligand-specific transactivation responses of the VDRB1 isoform. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15992766
|
Drezner MK and Nesbitt T |
Role of calcitriol in prevention of osteoporosis: Part I. |
1990 |
Metab. Clin. Exp. |
pmid:2325566
|
Skjødt H et al. |
Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro. |
1985 |
J. Endocrinol. |
pmid:3873510
|
Hove K |
Effects of 1 alpha-hydroxylated metabolites of cholecalciferol on intestinal radiocalcium absorption in goats. |
1984 |
Br. J. Nutr. |
pmid:6546296
|
Hove K et al. |
Effects of 1 alpha-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3, 1,24,25-trihydroxyvitamin D3, and 1,25,26-trihydroxyvitamin D3 on mineral metabolism and 1,25-dihydroxyvitamin D concentrations in dairy cows. |
1983 |
J. Dairy Sci. |
pmid:6687602
|
Reinhardt TA et al. |
A new in vivo metabolite of vitamin D3: 1,25,26-trihydroxyvitamin D3. |
1981 |
Biochem. Biophys. Res. Commun. |
pmid:6263274
|
Tanaka Y et al. |
1,25,26-trihydroxyvitamin D3: isolation, identification, and biological activity. |
1981 |
Arch. Biochem. Biophys. |
pmid:6895295
|
|
|
|
|
pmid:
|